Business & Regulation

It's time to develop an ethical code for the pharmaceutical industry.

Today, the majority of the contract manufacturing market is made up of small molecules.

FDA and EMA forge an agreement to mutually recognize drug manufacturing inspections.

The industry is scrambling to find more about therapeutic modulation of checkpoint signals.

Mark Paxton was appointed CEO of Rx-360 in 2015. Here, he discusses the journey so far

Donald Trump has vowed to lower drug prices, but what about his policies in other areas?

Could manufacturers based in Russia be well placed to develop cheaper biopharmaceuticals?

What better way to engage with patients than partnering with Marvel Custom Solutions?

A campaign to counter criticism and a first foray into biosimilars… What’s new in business?

What does the legalization of medical cannabis mean for conventional pharmaceuticals?